Entries by aaron

Which is better – intravenous or nebulized dexmedetomidine as premedication?

Recently published research paper investigates the comparative effectiveness of nebulized dexmedetomidine versus traditional intravenous administration in attenuating hemodynamic responses associated with laryngoscopy and tracheal intubation. The study involved 60 patients undergoing surgery under general anesthesia, who were randomly allocated into two groups receiving either intravenous or nebulized dexmedetomidine as premedication. The study found that nebulized […]

Water-Free Cyclosporine Solution may Improve Dry Eye Disease symptoms: JAMA

A recent study published in the recent edition of Journal of American Medical Association revealed promising results in the treatment of Dry Eye Disease (DED). This study focused was set out to evaluate the efficacy and safety of a water-free cyclosporine ophthalmic solution in Chinese participants with moderate to severe DED. The multicenter, double-blind, vehicle-controlled, phase […]

Exercise Caution: Meta-analysis reports significant prevalence of bleeding after PCI

Iran: A systematic review and meta-analysis has shown that the incidence of bleeding after PCI is 4.4 %, which is a significant result. The findings, published in the Indian Heart Journal, highlight the need for healthcare policymakers to pay more attention to the complications associated with PCI. The researchers suggest that interventional cardiologists should consider […]

High CRP in Metabolic Syndrome patients Linked to high Cancer Risk, finds study

Metabolic syndrome (MetS) has long been associated with an increased risk of cancer development. However, the dynamics of MetS over time and its correlation with cancer risk remain understudied. This study delves into the trajectories of MetS scores and their relationship with the onset of various cancers, shedding light on the importance of sustained monitoring […]

Elevated CSF glial fibrillary acid protein linked to nonrelapsing progressive multiple sclerosis: JAMA

USA: A recent cohort study published in JAMA Neurology has shed light on the emerging cerebrospinal fluid (CSF) biomarkers of disease activity and progression in multiple sclerosis. In the study, activated glial markers (glial fibrillary acid protein [GFAP] in particular) and neurofilament heavy chains were associated specifically with nonrelapsing progressive disease outcomes. Elevated CSF GFAP […]

MSR 2023: Now possible to open medical college with intake capacity of only 50 MBBS seats

It is now possible to open a medical college with an intake capacity of only 50 MBBS seats under the new Minimum Standard Requirements (MSR) 2023 regulations for undergraduate medical courses. “These new rules enable even smaller hospitals with a 220-bed capacity to start a medical college for 50 MBBS students,” the National Medical Commission […]

Understanding the Potential Role of Heavy Metal Toxicity in Autism – Dr Pradeep Mahajan

In recent years, there has been increasing interest in uncovering environmental factors that may contribute to autism spectrum disorder (ASD). One such factor that has garnered attention is heavy metal toxicity. Studies suggest that exposure to heavy metals like lead, mercury, and arsenic might influence the development and severity of autism symptoms in some individuals. […]

USFDA declines to approve Viatris-Mapi Pharma’s monthly multiple sclerosis injection

The U.S. FDA has declined to approve Viatris and Mapi Pharma’s once-a-month injection for treating relapsing forms of debilitating neurological condition multiple sclerosis (MS), the companies said. The companies were reviewing the content of the health regulator’s so called complete response letter (CRL) and would soon determine the appropriate next steps, they said, without disclosing further […]